Literature DB >> 11506851

Skin flux during reactive hyperemia and local hyperthermia in patients with preeclampsia.

E Beinder1, D Schlembach.   

Abstract

OBJECTIVE: To test the contribution of the endothelium to the maximum vasodilatation in patients with preeclampsia and healthy pregnant controls.
METHODS: Laser-Doppler flowmetry, which is a noninvasive method for the continuous measurement of skin blood flow, was used to test the response of skin microcirculation to the above-mentioned stimuli in 14 patients with preeclampsia and 20 normotensive pregnant controls.
RESULTS: In normotensive pregnant controls, the reactive hyperemic response after a 3-minute ischemia in the forearm reaches values of 77 +/- 16% of the maximum vasodilatation, which was induced by local hyperthermia of 42C. In patients with preeclampsia, this response was significantly (P <.05) reduced (43 +/- 9%).
CONCLUSION: Vascular reactivity is altered in skin vessels of patients with preeclampsia in vivo. This alteration seems to be attributable mainly to the endothelium.

Entities:  

Mesh:

Year:  2001        PMID: 11506851     DOI: 10.1016/s0029-7844(01)01456-9

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Abnormal microvascular reactivity with hypercholesterolaemia in pregnancy.

Authors:  Aida Hanum Ghulam Rasool; Aisyah Syairah Abdul Rahman; Nor Aliza Abd Ghaffar; Nik Mohd Zaki Nik Mahmood; Abd Rahim Wong
Journal:  Malays J Med Sci       Date:  2010-10

2.  Alteration of skin laser-Doppler flux response to local cooling in gestational hypertension.

Authors:  Ksenija Cankar; Nejka Potocnik; Martin Strucl
Journal:  Clin Auton Res       Date:  2010-01-09       Impact factor: 4.435

3.  Maternal Vascular Lesions in the Placenta Predict Vascular Impairments a Decade After Delivery.

Authors:  Janet M Catov; Matthew F Muldoon; Robin E Gandley; Judith Brands; Alisse Hauspurg; Carl A Hubel; Marie Tuft; Mandy Schmella; Gong Tang; W Tony Parks
Journal:  Hypertension       Date:  2021-12-09       Impact factor: 9.897

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.